Protagonist Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
33.00
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
2
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.87
|
-0.64
|
0.23
|
26.44%
|
|
2022-06-30
|
-0.93
|
-0.84
|
0.09
|
9.68%
|
|
2022-03-31
|
-0.63
|
-0.43
|
0.20
|
31.75%
|
|
2021-12-31
|
-0.78
|
-0.77
|
0.01
|
1.28%
|
|
2021-09-30
|
-0.67
|
-0.70
|
-0.03
|
-4.48%
|
|
2021-06-30
|
-0.55
|
-0.69
|
-0.14
|
-25.45%
|
|
2021-03-31
|
-0.57
|
-0.54
|
0.03
|
5.26%
|
|
2020-12-31
|
-0.48
|
-0.48
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.91
|
|
2021-12-31
|
-2.70
|
|
2020-12-31
|
-2.02
|
|
2019-12-31
|
-3.00
|
|
2018-12-31
|
-1.72
|
|
2017-12-31
|
-2.17
|
|
2016-12-31
|
-20.61
|